Tesla doesn’t deserve to be in the Magnificent Seven—and that means investors need a different strategy to trade the ever-controversial electric-vehicle maker.
Shumbayawonda et al. examine the impact of multi-parametric MRI in managing MASLD in a multinational randomised clinical trial. Findings show multi-parametric MRI is cost-effective, reduces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback